Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Endeavor BioMedicines

Request full access

Clinical-stage biotechnology company targeting the core drivers of terminal diseases including oncology and fibrosis

San Diego, United StatesFounded 2018Biotech & Life Sciences

About Endeavor BioMedicines

Endeavor BioMedicines is a biotech startup that operates in the healthcare sector, specifically in the development of targeted therapies for terminal diseases such as fibrosis and cancer. Their primary goal is to improve the quality of life and longevity of patients suffering from these conditions.

The company's business model revolves around the research, development, and commercialization of innovative, best-in-class medicines. They use a data-driven approach, leveraging the extensive experience of their team in the biotech and clinical development fields. This allows them to create targeted treatments that are more effective and have fewer side effects than traditional therapies.

Endeavor BioMedicines serves a broad range of clients, primarily patients suffering from terminal diseases. However, their market also includes healthcare providers and institutions that administer their treatments, as well as insurance companies that cover the cost of these therapies.

The company generates revenue through the sale of their developed drugs. This typically involves a lengthy process of research and development, followed by clinical trials, and finally, if successful, commercial sale. The profitability of the company is therefore dependent on the successful development and approval of their drugs.

In summary, Endeavor BioMedicines is a patient-focused biotech company that uses a data-driven approach to develop targeted therapies for terminal diseases, with the aim of improving patient outcomes and quality of life.

Source: Dealroom company data

At a glance

Status
Operational
Employees
50
Open positions
None listed
Dealroom signal
77.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Oncology, Biotech and Pharma, Hard Tech, Longevity, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Apr 2024 $133M $530M Fidelity Investments · Invus · Matrix Capital Management · T. Rowe Price ↗
SERIES BOther financing Feb 2022 $101M $404M Tekla Capital Management · Omega Funds · T. Rowe Price · Piper Heartland Healthcare Capital ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Endeavor BioMedicines website traffic

Latest recorded traffic for Endeavor BioMedicines is 3.6K monthly website visits, up 71.4% over the last three months. Endeavor BioMedicines's team grew 4.2% over the past year.

Latest monthly visits3.6K 3-month web change+71.4% 1-year team growth+4.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Endeavor BioMedicines in the San Diego ecosystem

Live from Dealroom

The Endeavor BioMedicines office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

18 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A9 investors entered at this stage

  • Longitude Capital
  • Omega Funds
  • Ally Bridge Group
  • Tekla Capital Management
  • T. Rowe Price
  • Piper Heartland Healthcare Capital
  • Perceptive Advisors
  • Revelation Partners
  • Avidity Partners

Series B and later9 investors entered at this stage

  • Fidelity Investments
  • Invus
  • Matrix Capital Management
  • Silver Arch Bio
  • Woodline Partners
  • Velosity Capital
  • Aberdeen
  • SymBiosis
  • Eckuity
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States94.7%
🇲🇽 Mexico2.6%
🇬🇧 United Kingdom2.6%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Endeavor BioMedicines on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Endeavor BioMedicines’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.